Literature DB >> 2227495

Toxicity and clearance of intravitreal cefotetan.

W Philipp1, K Schmid, H J Steiner, B Pümpel, F Allerberger, H P Aichberger, W Mayer.   

Abstract

Direct intravitreal injection of antibiotics plays an important role in the management of bacterial endophthalmitis. In the present study we investigated the toxicity and clearance of intravitreally injected cefotetan in a rabbit model. No toxic ocular side effects could be detected by electroretinography (ERG) or light and electron microscopy up to and including a single intravitreal dose of 1000 micrograms. Intravitreal injection of 2000 micrograms cefotetan resulted in mild degeneration of photoreceptor outer segments and, sporadically, in cataract formation. After intravitreal injection of 4000 micrograms, moderate toxic degeneration of photoreceptors occurred, with displacement and mitochondrial swelling of inner segments. In addition, lysosomal lamellar inclusion bodies could be detected in pigment epithelial cells. After a single intravitreal injection of 1000 micrograms cefotetan, concentrations greater than the minimum necessary for the inhibition of most commonly occurring intraocular pathogens (except Pseudomonas aeruginosa and Staphylococcus epidermidis) were maintained in the vitreous humor for greater than 48 h. Cefotetan may be a potentially important drug for intravitreal injection, especially in cases of gram-negative and suspected anaerobic endophthalmitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227495     DOI: 10.1007/bf00927265

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  36 in total

1.  In vivo measurement of optic-disk oxygen tension.

Authors:  J T Ernest
Journal:  Invest Ophthalmol       Date:  1973-12

2.  Late endophthalmitis after filtering surgery.

Authors:  J M Hattenhauer; M P Lipsich
Journal:  Am J Ophthalmol       Date:  1971-12       Impact factor: 5.258

3.  BB-K8: A new aminoglycoside for intravitreal injection in bacterial endophthalmitis.

Authors:  P Nelsen; G A Peyman; T O Bennett
Journal:  Am J Ophthalmol       Date:  1974-07       Impact factor: 5.258

4.  Activity in vitro of cefotetan against non-sporing anaerobes: a comparative study.

Authors:  G Ruckdeschel
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

5.  The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitis.

Authors:  G A Peyman; D W Vastine; H I Meisels
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

6.  Posttraumatic endophthalmitis.

Authors:  G S Brinton; T M Topping; R A Hyndiuk; T M Aaberg; F H Reeser; G W Abrams
Journal:  Arch Ophthalmol       Date:  1984-04

7.  Intravitreal cephalothin in experimental staphylococcal endophthalmitis.

Authors:  J J Rutgard; R A Berkowitz; G A Peyman
Journal:  Ann Ophthalmol       Date:  1978-03

8.  Infectious endophthalmitis. Review of 36 cases.

Authors:  C A Puliafito; A S Baker; J Haaf; C S Foster
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

9.  Cefotetan: in-vitro antibacterial activity and susceptibility to beta-lactamases.

Authors:  I Phillips; A King; K Shannon; C Warren
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

10.  The intravitreal use of carbenicillin (Geopen) for treatment od pseudomonas endophthalmitis.

Authors:  A G Schenk; G A Peyman; J T Paque
Journal:  Acta Ophthalmol (Copenh)       Date:  1974
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.